Galmed Pharmaceuticals LTD. (GLMD) SEC Filings — 2024
22 SEC filings for Galmed Pharmaceuticals LTD. (GLMD) in 2024.
Filings
- Galmed Pharmaceuticals LTD. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Galmed Pharma Files 6-K with Q3 2024 Financials — 6-K · Nov 14, 2024
- Galmed Pharmaceuticals Holds Shareholder Meeting — 6-K · Oct 21, 2024
- Galmed Pharma Shareholder Meeting Adjourned Due to Lack of Quorum — 6-K · Oct 15, 2024
- Galmed Pharma Publishes Aramchol Phase 3 Results — 6-K · Sep 25, 2024
- Galmed Pharmaceuticals LTD. SC 13G/A Filing — SC 13G/A · Sep 20, 2024
- Galmed Pharmaceuticals Sets Shareholder Meeting for Oct 14 — 6-K · Sep 20, 2024
- Galmed Pharmaceuticals Expands Focus to Cancer & Cardiometabolic Diseases — 6-K · Sep 19, 2024
- Galmed Pharma Regains Nasdaq Listing Compliance — 6-K · Sep 16, 2024
- Galmed Pharma Secures Up to $10M Equity Line with Yorkville — 6-K · Aug 30, 2024
- Galmed Pharma Files 6-K with Q2 2024 Financials — 6-K · Aug 28, 2024
- Galmed Pharma to enact 1-for-12 reverse stock split — 6-K · Aug 27, 2024
- Galmed Pharmaceuticals Ltd. Holds Annual Shareholder Meeting — 6-K · Jul 18, 2024
- Galmed Pharma Annual Meeting Adjourned Due to Lack of Quorum — 6-K · Jul 11, 2024
- Galmed Pharmaceuticals Sets July 10th Annual Shareholder Meeting — 6-K · Jun 5, 2024
- Galmed Pharma Files Q1 2024 Financials — 6-K · May 30, 2024
- Galmed Pharmaceuticals Ltd. Files 20-F Annual Report — 20-F · Apr 4, 2024
- Galmed Pharma Faces Nasdaq Bid Price Deadline — 6-K · Mar 19, 2024
- Galmed Pharma Secures New Patent for NASH Drug Combo — 6-K · Mar 15, 2024
- Galmed Pharmaceuticals LTD. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Galmed Pharmaceuticals LTD. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- G. Yarom Medical Research Ltd. Reports 0% Stake in Galmed Pharma — SC 13G/A · Feb 12, 2024